IMPRESS I & II – demonstrating efficacy and safety1

The effectiveness of Xiapex in helping to straighten the curve of an erection has been demonstrated in 2 large clinical studies involving over 800 men. In 2 large clinical studies, men with Peyronie’s disease who received up to 4 treatment cycles of Xiapex saw a significant improvement in the curve of their erections, compared to men who were not treated with Xiapex.

In the first study, men who received Xiapex had an average reduction in their curve of 35 %, compared to 18 % in men who didn’t receive Xiapex.

In the second study, men who received Xiapex had an average reduction in their curve of 33%, compared to 22% for men who didn’t receive Xiapex.

These large, double-blind, placebo controlled studies support the efficacy and safety of Xiapex treatment for the physical and psychological aspects of PD. In IMPRESS I and II Xiapex treated men showed a significantly greater percent reduction in the penile curvature abnormality and significantly greater improvement in subject reported PD bother compared with placebo.

IMPORTANT

Xiapex was not associated with shortening of penile length in clinical trials in the treatment of Peyronie´s disease.1


Are you a healthcare professional?

Dupuytren’s disease

Peyronie’s disease